Insider Transactions in Q1 2023 at Sea Spine Holdings Corp (SPNE)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2023
|
John B Henneman Iii Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
82,654
-100.0%
|
-
|
|
Jan 05
2023
|
Michael Fekete Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
111,966
-100.0%
|
-
|
|
Jan 05
2023
|
Renee Gaeta Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
36,056
-100.0%
|
-
|
|
Jan 05
2023
|
Shweta Maniar Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
23,993
-100.0%
|
-
|
|
Jan 05
2023
|
Angela Steinway Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
23,725
-100.0%
|
-
|
|
Jan 05
2023
|
Kirtley C. Stephenson Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
9,700
-100.0%
|
-
|
|
Jan 05
2023
|
Kirtley C. Stephenson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
128,640
-100.0%
|
-
|
|
Jan 05
2023
|
Keith Valentine Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
333,797
-100.0%
|
-
|
|
Jan 05
2023
|
John J. Bostjancic Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
102,563
-100.0%
|
-
|
|
Jan 05
2023
|
Paul S. Benny VP, Treasurer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,950
-100.0%
|
-
|
|
Jan 05
2023
|
Dennis Cirino SVP, Global Spinal Systems |
SELL
Sale (or disposition) back to the issuer
|
Direct |
48,556
-100.0%
|
-
|
|
Jan 05
2023
|
Patrick L Keran SVP, General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
69,628
-100.0%
|
-
|
|
Jan 05
2023
|
Tyler Lipschultz SVP, Orthobiologics and BD |
SELL
Sale (or disposition) back to the issuer
|
Direct |
131,284
-100.0%
|
-
|
|
Jan 05
2023
|
John J. Winge Vice President, Sales |
SELL
Sale (or disposition) back to the issuer
|
Direct |
90,951
-100.0%
|
-
|
|
Jan 05
2023
|
Stuart Essig Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
460,275
-100.0%
|
-
|
|
Jan 05
2023
|
Keith Bradley Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
88,592
-100.0%
|
-
|
|
Jan 01
2023
|
Keith Valentine Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,170
-2.1%
|
$57,360
$8.35 P/Share
|
|
Jan 01
2023
|
Keith Valentine Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,183
+3.45%
|
-
|
|
Jan 01
2023
|
John J. Bostjancic Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,281
-3.1%
|
$26,248
$8.35 P/Share
|
|
Jan 01
2023
|
John J. Bostjancic Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,575
+5.0%
|
-
|
|
Jan 01
2023
|
Paul S. Benny VP, Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
425
-1.99%
|
$3,400
$8.35 P/Share
|
|
Jan 01
2023
|
Paul S. Benny VP, Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,041
+4.64%
|
-
|
|
Jan 01
2023
|
Dennis Cirino SVP, Global Spinal Systems |
SELL
Payment of exercise price or tax liability
|
Direct |
3,150
-6.09%
|
$25,200
$8.35 P/Share
|
|
Jan 01
2023
|
Dennis Cirino SVP, Global Spinal Systems |
BUY
Exercise of conversion of derivative security
|
Direct |
5,352
+9.38%
|
-
|
|
Jan 01
2023
|
Patrick L Keran SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,108
-4.27%
|
$24,864
$8.35 P/Share
|
|
Jan 01
2023
|
Patrick L Keran SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,280
+6.77%
|
-
|
|
Jan 01
2023
|
Tyler Lipschultz SVP, Orthobiologics and BD |
SELL
Payment of exercise price or tax liability
|
Direct |
3,411
-2.53%
|
$27,288
$8.35 P/Share
|
|
Jan 01
2023
|
Tyler Lipschultz SVP, Orthobiologics and BD |
BUY
Exercise of conversion of derivative security
|
Direct |
8,362
+5.85%
|
-
|
|
Jan 01
2023
|
John J. Winge Vice President, Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
2,490
-2.66%
|
$19,920
$8.35 P/Share
|
|
Jan 01
2023
|
John J. Winge Vice President, Sales |
BUY
Exercise of conversion of derivative security
|
Direct |
4,868
+4.95%
|
-
|